Mortality News and Research

RSS

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

In a recent bioRxiv* preprint paper, researchers isolated anti-RBD nanobodies from llamas and “nanomice” (they engineered to produce VHHs cloned from alpacas, dromedaries and camels).

10 Mar 2021

Study: COVID-19 test package can reduce infections and mortality at justifiable cost

Mailing a package of SARS-CoV-2 tests to every household in America and asking people to use them once a week could greatly reduce total infections and mortality at a justifiable cost, a new study led by the Yale School of Public Health finds.

10 Mar 2021

New strategy may solve challenges associated with "healthcare big data"

The efficient provision of medical care is integral to society. Over time, the healthcare industry has tapped into modern technology in order to keep up its quality of service.

10 Mar 2021

UK variant of SARS-CoV-2 could be more deadly than previous strains

Researchers have conducted a study showing that the B.1.1.7 variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has emerged in the UK is associated with a significantly increased risk of death compared with the viral strain previously circulating in the country.

9 Mar 2021

Sugar-sweetened soda intake associated with increased risk of mortality among breast cancer patients

New research from the University at Buffalo suggests that breast cancer patients who drink sugar-sweetened beverages regularly are at increased risk for death from any cause and breast cancer in particular.

9 Mar 2021

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

Scientists from the United States has recently evaluated the safety and efficacy profiles of ultraviolet-A (UVA) light applied via an endotracheal tube to critically ill COVID-19 patients.

9 Mar 2021

New research project aims to treat patients with secondary brain damage

The Universities of Birmingham and Cambridge have launched a new research project aimed at discovering if selective P2X7 receptor blocker drugs can be repurposed to treat patients with secondary brain damage.

9 Mar 2021

Transmission risk for schistosomiasis peaks at higher water temperature

About one billion people worldwide are at risk for schistosomiasis -- a debilitating disease caused by parasitic worms that live in fresh water and in intermediate snail hosts.

9 Mar 2021

Over half million Americans are exposed to oil and gas “flaring” events

Researchers from the UCLA Fielding School of Public Health and the University of Southern California have found that more than a half million Americans are exposed to oil and gas "flaring" events - the burning off of excess natural gas at production sites - resulting in potentially serious health risks.

9 Mar 2021

Compounds in green and black tea relax blood vessels by activating ion channel proteins

A new study from the University of California, Irvine shows that compounds in both green and black tea relax blood vessels by activating ion channel proteins in the blood vessel wall.

8 Mar 2021

Researchers identify new biomarkers associated with severity of COVID-19

A team of researchers from the CHUM Research Centre has identified new biomarkers associated with the severity of COVID-19 in infected patients.

8 Mar 2021

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India -- one of the world's most ethnically diverse countries.

8 Mar 2021

Monoclonal antibodies can be an effective tool in the global fight against malaria

Scientists at Walter Reed Army Institute of Research, in collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria.

8 Mar 2021

Despite modest progress, maternal and child undernutrition remains a key health concern

The Lancet today published the latest Series on Maternal and Child Undernutrition Progress, including three new papers that build upon findings from the previous 2008 and 2013 Series, which established an evidence-based global agenda for tackling undernutrition over the past decade.

8 Mar 2021

Mortality News and Research

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Study: COVID-19 test package can reduce infections and mortality at justifiable cost

New strategy may solve challenges associated with "healthcare big data"

UK variant of SARS-CoV-2 could be more deadly than previous strains

Sugar-sweetened soda intake associated with increased risk of mortality among breast cancer patients

Ultraviolet light therapy reduces viral load in critically ill COVID-19 patients

New research project aims to treat patients with secondary brain damage

Transmission risk for schistosomiasis peaks at higher water temperature

Over half million Americans are exposed to oil and gas “flaring” events

Compounds in green and black tea relax blood vessels by activating ion channel proteins

Researchers identify new biomarkers associated with severity of COVID-19

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Monoclonal antibodies can be an effective tool in the global fight against malaria

Despite modest progress, maternal and child undernutrition remains a key health concern

Study analyzes COVID fatality rate using age and GDP as proxies for the quality and abundance of healthcare

People with vision impairment have higher risk of all-cause mortality

Specific brain regions respond opposingly to emotions linked with loneliness and wisdom

Combined liver-cytokine humanization enhances human red blood cell production and survival

One dose of SARS-CoV-2 vaccine candidate boosts neutralizing antibody response in COVID-19 convalescents

A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News